Amendia Inc. Invests $50 Million in Implant Spinoff  
4/12/2013 9:11:30 AM

Specialty medical-device manufacturer Amendia Inc. will invest up to $50 million to commercialize a biomedical spinoff that focuses on implant technology and stem cell therapies. The new venture, Vivex Biomedical Inc., is developing implant technology to help stimulate bone regrowth. Vivex has also licensed a highly adaptive adult stem cell line, known as MIAMI (Marrow Isolated Adult Multi-lineage Inducible) cells.